Camouflaged WeChat Mini-program-based Intervention for Women Victims of Intimate Partner Violence: Protocol for a Pilot Mixed Methods Study
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 86
- 试验地点
- 1
- 主要终点
- Feasibility and acceptability of the WOMEN Health programme
研究概览
简要总结
Intimate partner violence (IPV) is a major public health issue and human rights threat worldwide, especially for Chinese immigrant women victims in Hong Kong. Interventions that address negative physical and emotional outcomes from IPV could therefore play a crucial role in enhancing empowerment, social support, and healthy lifestyle among these women. The overall objective of this pilot mixed methods study is to determine the feasibility and acceptability of a camouflaged WeChat mini-program-based WOMEN Health intervention for women victims of IPV. This study will evaluate the feasibility and acceptability of a camouflaged WeChat mini-program-based WOMEN Health intervention for women victims of IPV.
详细描述
Intimate partner violence (IPV) is a major public health issue and human rights threat worldwide, especially for Chinese immigrant women victims in Hong Kong. Interventions that address negative physical and emotional outcomes from IPV could therefore play a crucial role in enhancing empowerment, social support, and healthy lifestyle among these women. Previous studies in Hong Kong and the United States provided evidence on IPV interventions among Chinese abused women; however, there is a scarcity of evidence on the use of mHealth for abused women while fully considering their safety studies on mobile technology for Chinese immigrant women victims are limited, and there lacks safe, low-cost, and evidence-based mHealth interventions for empowering and supporting women victims who immigrate to Hong Kong and face more vulnerabilities and needs. This study will evaluate the feasibility and acceptability of a camouflaged WeChat mini-program-based WOMEN Health intervention for women victims of IPV.
This pilot mixed methods study will adopt the randomized, wait-list controlled trial with two groups (1:1 ratio), followed by in-depth interviews with participants in the WOMEN Health programme group at post-intervention. It will evaluate feasibility and acceptability as the primary outcomes and compare scores changes after 12 weeks interventions between Chinese immigrant women who are screened positive for IPV randomly assigned to receiving genuine IPV intervention and disguised healthy lifestyle intervention, and Chinese immigrant women who are screened positive for IPV in a control procedure. The wait-list control group will also receive the WOMEN Health programme after the intervention group completed the programme.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Supportive Care
- 盲法
- Single (Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 45 Years(Adult)
- 性别
- Female
- 接受健康志愿者
- 是
入选标准
- •Chinese-speaking (Mandarin or Cantonese)
- •women aged 18 to 45 years
- •originally from mainland China and have moved to Hong Kong for at least one year
- •screened positive for IPV during heterosexual relationships in the past year
- •have a smartphone with WeChat installed
- •with no plans to move outside Hong Kong in the next one year
排除标准
- •unwilling to provide informed consent
- •severe chronic diseases (e.g., cancer, heart failure, kidney failure, chronic obstructive pulmonary disease, and HIV/AIDS)
- •currently experience severe IPV (identified using the revised 11-item Danger Assessment)
研究组 & 干预措施
WOMEN Health group
The WOMEN Health programme
干预措施: WOMEN Health programme (Behavioral)
Wait-list control group
Healthy lifestyle intervention
干预措施: Wait-list control group (Behavioral)
结局指标
主要结局
Feasibility and acceptability of the WOMEN Health programme
时间窗: Week 12
Feasibility and acceptability will be assessed using a 12-item self-developed questionnaire. Items are rated on a 5-point Likert scale (1-5), with higher scores indicating greater acceptability, satisfaction, and usefulness.
次要结局
- Changes in depressive symptoms(Baseline and Week 12)
- Changes in quality of life(Baseline and Week 12)
- Changes in intimate partner violence (IPV)(Baseline and Week 12)
- Changes in Body Mass Index (BMI)(Baseline and up to 12 weeks)
- Changes in healthy behaviors(Baseline and Week 12)
